December 10, 2016 6:15 PM ET

Biotechnology

Company Overview of TEI Biosciences Inc.

Company Overview

TEI Biosciences Inc., a biomedical company, develops, manufactures, markets, and sells biologic devices for the repair, reinforcement, or reconstruction of human tissues that have failed due to aging, injury, or disease in the United States and internationally. The company offers its biologic devices for soft tissue repair and regenerative applications, including dura and hernia repair, and plastic and reconstructive surgery. Its products include SurgiMend, a cellular collagen matrix derived from fetal and neonatal bovine dermis; SurgiMend-e, a family of collagen matrices for soft tissue reconstruction; SurgiMend PRS, a acellular biologic matrix designed for plastic and reconstructive surger...

1000 Winter Street

Waltham, MA 02451

United States

Founded in 1993

Phone:

617-268-1616

Fax:

781-609-2044

Key Executives for TEI Biosciences Inc.

Chairman, Chief Executive Officer and President
Age: 55
Director of Finance
Vice President of Product Sciences and Regulatory Affairs
Vice President of Manufacturing and Quality
Director of Manufacturing
Compensation as of Fiscal Year 2016.

TEI Biosciences Inc. Key Developments

Integra LifeSciences Holdings Corporation, TEI Biosciences Inc., TEI Medical Inc. - M&A Call

To discuss definitive agreement under which Integra will acquire all of the outstanding shares of TEI Biosciences, Inc. and TEI Medical, Inc

TEI Biosciences Receives Contract from Health Resource Services

TEI Biosciences Inc. announced that it has signed an agreement with Health Resource Services, LLC (HRS) for its SurgiMendĀ® Collagen Matrix for Soft Tissue Reconstruction. The three year agreement is effective May 1, 2015 and will make SurgiMend available to the HRS network, which includes over 150 acute care and teaching hospitals in more than 20 states throughout the country.

TEI Biosciences Inc. Receives Major Contract with Novation

TEI Biosciences Inc. announced that it has signed a national agreement with Novation. The three-year contract begins April 1st, 2015, and will make TEI's biologic mesh available to more than 100,000 members and affiliates of VHA Inc., UHC, Children's Hospital Association and Provista LLC.

Similar Private Companies By Industry

Company Name Region
20n Labs, Inc. United States
23andMe, Inc. United States
2C Tech Corporation, Inc. United States
3-V Biosciences, Inc. United States
3D Bio Holdings LLC United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Bloomberg L.P. United States
The Advertising Council, Inc. United States
Rush University United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact TEI Biosciences Inc., please visit www.teibio.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.